LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 6.06 | 84.90 | 788 | 365 | 2.1562 | 1.8806 | MN20160318_Q02 | C21 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 6.06 | 84.90 | 579 | 365 | 1.5843 | 1.4884 | MN20160318_Q02 | C13 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 6.06 | 84.90 | 4 | 365 | 0.0109 | -0.7656 | MN20160318_Q02 | C21 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 6.06 | 84.90 | 670 | 365 | 1.8333 | 1.6671 | MN20160318_Q02 | E14 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | G20 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 6.06 | 84.90 | 3 | 365 | 0.0082 | -0.7955 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 6.06 | 84.90 | 642 | 365 | 1.7567 | 1.6135 | MN20160318_Q02 | D19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | C12 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | D19 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 6.06 | 84.90 | 818 | 365 | 2.2383 | 1.9322 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | J10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 6.06 | 84.90 | 3 | 365 | 0.0082 | -0.7955 | MN20160318_Q02 | L22 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 6.06 | 84.90 | 745 | 365 | 2.0386 | 1.8049 | MN20160318_Q02 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 6.06 | 84.90 | 756 | 365 | 2.0687 | 1.8245 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | C13 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 6.06 | 84.90 | 836 | 365 | 2.2876 | 1.9627 | MN20160318_Q02 | J10 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 6.06 | 84.90 | 9 | 365 | 0.0246 | -0.6555 | MN20160318_Q02 | M18 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.0033333 | 6.06 | 84.90 | 18 | 365 | 0.0493 | -0.5212 | MN20160318_Q02 | M22 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 6.06 | 84.90 | 743 | 365 | 2.0331 | 1.8013 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 6.06 | 84.90 | 4 | 365 | 0.0109 | -0.7656 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.01 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | J15 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.0033333 | 6.06 | 84.90 | 789 | 365 | 2.1590 | 1.8824 | MN20160318_Q02 | J09 |